A prospective, multi-center, randomized, double blinded, placebo-controlled study for the evaluation of Iloprost in the early postoperative period after liver transplantation - PRAISE-Study
Phase of Trial: Phase III
Latest Information Update: 12 Sep 2016
At a glance
- Drugs Iloprost (Primary)
- Indications Ischaemia; Thrombosis
- Focus Pharmacodynamics
- Acronyms PRAISE
- 27 Feb 2016 Status changed from recruiting to completed as reported by ISRCTN record.
- 16 Jul 2012 Trial design presented at the 24th International Congress of the Transplantation Society.
- 11 Apr 2012 Additional trial centres and trial conpanies (Bayer Vital, Astellas Pharma) added as reported by German Clinical Trials Register.